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ABSTRACT 
Enzymic removal of sialyl groups from mammalian erythrocytes resulted in 
their rapid sequestration from circulation subsequent to autologous transfusion. It 
has been demonstrated by many investigators that the terminal /3-D-galactosyl 
group, exposed on red blood cell by in vitro desialosylation, is recognized by an 
autoimmune anti-galactosyl IgG and/or by a lectin-like receptor on monocytes and 
macrophages. It is demonstrated herein that the disaccharide structure P-D-Galp- 
(1+3)-o-GalpNAc (a) is masked in normal rat RBC, but exposed in asialo-RBC; 
(b) could be detected with fluorescently-labeled peanut agglutinin; (c) could be 
released from the asialo-RBC with an endo-N-acetyl-cY-o-galactosaminidase; and 
(d) upon its removal by treatment with the endo-N-acetyl-a-D-galactosaminidase, 
enhances the survival of the asialo-RBC in circulation. 
JNTRODUCTION 
Enzymic removal of sialyl groups from mammalian erythrocytes (RBC) 
resulted in their rapid sequestration from circulation’. With the demonstration that 
the sialic acid content of RBCs decreases with their in vivo aging in circulationz, it 
has been postulated that a removal of sialyl groups might be involved in in vivo 
aging of RBC, with consequent sequestration of the RBC when the sialic acid 
content dropped by lO-15% to a threshold value3. Evidence from a number of 
studies in our laboratory has shown that in both artificial removal of sialyl groups 
from RBC with sialidase from Vibrio cholerae, aRBC, and in vivo aging of RBC in 
circulation, the loss of sialic acid groups is accompanied by the unmasking of the 
penultimate /3-D-galactosyl residues. This is analogous to the Ashwell and Morel1 
system for the sequestration of asialo plasma glycoproteins by hepatocytes4. In 
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contrast, we have shown that asialo RBC involve interaction with liver Kupffcr 
cells and spleen monocyte9. 
We believe that the in vivo aging of RBC in circulation involves the 
desialosylation of glycophorin A, the most abundant sialoglyconjugate on human 
RBC surface. The hypothesis is supported by the isolation6 of a “senescence factor 
glycopeptide” (SFC) from the tryptic digest of intact human RBC. This glyco- 
peptide, free of all sialic acid groups, had all the properties expected of the 
“senescence factor” with the capacity to inhibit erythrophagocytosis of senescent 
RBCs by autologous human blood monocytes in nanomolur concentrations, in 
contrast to D-galactose alone, which inhibited at millimolar concentrations, and 
/3-o-galactosyl groups bound to bovine serum albumin which inhibited at micro- 
molar concentrations7. 
The well known susceptibility of glycophorin A to tryptic digestionx,9, and 
the method of purification devised6 for the isolation of SFG would point to glyco- 
phorin A as the putative parent molecule of SFG on human and other mammalian 
RBC surfaces. Nonetheless, it could be argued that SFG still was contaminated 
with a potent inhibitor of erythrophagocytosis of an as yet unidentified origin. The 
objective of this communication is to provide yet another and more direct approach 
to elucidate the role of glycophorin-like structures, recently characterized’” in rat 
RBC, in the sequestration of asialo RBC. Here, we focus on the disaccharide 
structure, P-o-Galp-(1-+3)-D-GalpNAc, and demonstrate that: (a) It is masked in 
normal RBC, but exposed in asialo RBC (aRBC); (b) it can be detected with 
fluorescein isothiocyanate-labeled peanut agglutinin (FITC-PNA); (c) it can be 
released from the aRBC with endo-iV-acetyl-cr-D-galactosaminidase (endo- 
glycosidase)“~‘“; and (d) upon its release with the endoglycosidase treatment, the 
survival of the aRBC in circulation is enhanced i3,i4. As previously, the Sprague- 
Dawley rat was used as the experimental model. 
EXPERIMENTAL 
Materials. - The following enzymes were obtained from the sources 
indicated: P-D-galactosidase from bovine testes was a gift from Dr. G. W. Jourdian, 
University of Michigan Is; V. cholerae sialidase was obtained from Worthington 
Biochemical Corp. ; and endo-N-acetyl-cu-D-galactosaminidase was prepared in our 
laboratory from Clostridium perfringens1’.12. FITC-PNA, was obtained from Sigma 
Chemical Co. (St. Louis, MO); and Sprague-Dawley rats from Charles River 
Breeding Laboratories, Inc. (Wilmington, MA). Naz5’Cr0, used for in vitro 
labeling of RBC was purchased from E. R. Squibb and Sons, Inc. (Princeton, NJ). 
Treatment of rat RBC with enzymes to determine their qffect on the survival of RBC 
in circulation 
Incubation of rat RBC with glycosidases. - Whole blood was obtained in a 
heparinized syringe by cardiac puncture of an approximately 400 g, male Sprague- 
Dawley rat. The blood was centrifuged, and the plasma and buffy coat were dis- 
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carded. The remaining packed cells were washed three times with isotonic saline 
solution. Four eyuivolume samples of RBC were incubated with the following 
reagents made up in isotonic saline solution at pH 5.5: (a) Isotonic saline control, 
(b) sialidase from V. cholerae (0.2 units/ml of packed cells), (c) sialidase from V. 
cholerae (0.2 units/ml of packed cells) and endoglycosidase (0.15 units/ml of 
packed cells), and (d) sialidase from V. cholerae (0.2 units/ml of packed cells) and 
P-D-galactosidase from bovine testes (0.15 units/ml of packed cells). The 
incubations were carried out for 1 h at 37”. 
Quantitative determination of FITC-PNA adsorption on enzymically treated 
rut RBC. - Upon completion of the incubation period, the samples were 
centrifuged and the supernatant discarded. The samples then were washed twice 
with phosphate-buffered saline solution (pH 7.3) (PBS). Aliquots of packed cells 
containing 1 x 10’ erythrocytes were removed from each of the samples and diluted 
to a volume of 100 PL with PBS. To these dilute red cell suspensions was added a 
1: 20 dilution of FITC-PNA of 0.1% solution in PBS (100 pL). The resulting 200-PL 
samples in triplicate were incubated for 1 h at 4”, and then centrifuged. Equal 
volumes of supernatant were removed from each sample and diluted to a total 
volume of 3 mL with isotonic saline solution adjusted to pH 9.0 to enhance the 
fluorescence. The fluorescence was measured with a Turner Model 430 spectro- 
fluorometer at excitation and emission settings of 498 nm and 534 nm, respectively. 
The measured fluorescence is that of unadsorbed fluorescent lectin. The determina- 
tion was made possible by comparison to a set of calibration standards of the 1:20 
dilution of 0.1% FITC-PNA in isotonic saline solution adjusted to pH 9.0. The 
amount of adsorbed FITC-PNA then was calculated by subtraction of the amount 
not adsorbed from the total FITC-PNA added to the sample. This procedure was 
adopted in order to shorten the assay. Previous experiments indicated that all the 
adsorbed FITC-PNA could be quantitatively eluted with 0.4~ lactose. Results are 
shown in Table I. 
Survival of radioactively-labeled and enzymically treated rat RBC in circula- 
tion. -Comparable enzymically-treated RBCs (Samples a-d), 4.0-6.5 X lo9 RBC, 
were washed and incubated for 0.5 h at 37” with Na,WrO, (50 PCi) to label the 
RBC. The resulting incubation mixtures were centrifuged to remove the unin- 
corporated Na,WrO, and washed until no more perceptible radioactivity remained 
in the washes; -95% of the radioactivity was incorporated into the RBC. Each 
pellet of RBCs was suspended in saline solution (-1 mL) and the RBC suspension 
(2 mL) injected intraperitoneally into each rat13J4. Enough RBC incubation 
mixtures of a-d were prepared to inject two rats per treatment. After 24 h, blood 
(20 PL) was removed from the tail of each rat and suspended in saline solution (480 
pL). Similar blood samples were removed at daily intervals, and all samples were 
stored at 4”. The radioactivity was counted simultaneously at the end of the 
experiment in a Packard gamma-counter. The per cent of radioactivity remaining 
in the blood samples was computed as a percentage of that found at the end of the 
first 24 h. The results are shown in Fig. 1. 
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RESULTS 
In view of the marked difference in the molecular extinction coefficient of 
sialic acid in the TBA assay I6 the disaccharide in the modified Morgan-Elson , 
assayr7, and I>-galactose with the galactose-dehydrogenase assay’“. it was 
impractical to photometrically monitor the action, on the aRBC of the endo-glyco- 
sidase and bovine testes P-r>-galactosidase. Instead, the process was monitored by 
determining the amount of FITC-PNA that was adsorbed on the aRBC’“. The 
peanut agglutinin was chosen deliberately to monitor the changes on RBC surface 
resulting from the enzymic treatments. This lectin focuses our attention only on the 
r>-galactosyl group (of the many exposed by removal of sialyl groups from RBC) 
that is present as the disaccharide residue, P-D-Galp-(1+3)-t~-Gal~NAc20. Normal 
rat RBCs do not adsorb significant amounts of FITC-PNA; after desialosylation, 
Days Post i.p. Injection of Labeled RBC 
Fig. 1. Survival of enzymically treated rat RBC in circulation: (-O-3-D) Control RBC, in isotonic RBC 
at pH 5.5; (-3-O-O-) sialidase-treated RBC; (-+-++-) _. I’d sla I ase- plus endoglycosidase-treated RBC: 
and (-O-O-c>-) sialidase- plus P-n-galactosidase-treated RBC. 
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they are very reactive, and the amount of lectin adsorbed is proportional to the 
number of aRBCs present. Under our standardized conditions, we arbitrarily 
assigned the amount of FITC-PNA bound to RBC as loO%, and then determined 
the effect of the two enzymes, /3-D-galactosidase from bovine testes and the Cl. 
perfringens endoglycosidase, on the extent of FITC-PNA that still could bind, 
giving us a figure of 55 and 12%, respectively (Table I). Within the limitations of 
the data presented and under the conditions of this assay at pH 5.5 and 37”, it is 
apparent that the endoglycosidase is more effective than the /3-u-galactosidase in 
removing the PNA reactive sites. 
We have demonstrated previously ‘%I4 that intraperitoneal transfusion is an 
extremely useful procedure for the transfer of relatively large numbers of RBCs. 
Normal untreated RBCs are recovered almost quantitatively in the general circula- 
tion within 22 h, whereas aRBCs appear preponderantly in the liver with only a few 
cells remaining in the peritoneal cavity. By use of the same procedure, it was possi- 
ble to monitor the survival of the enzyme-treated and -untreated RBCs remaining 
in circulation over a 12-day period. The mean results from two experiments are 
shown in Fig. 1, from which one may readily compare (a) the 50% survival of 
RBCs in circulation, and (b) the per cent of RBCs surviving after 12 days. namely, 
55 *IO% for the untreated control RBCs, 12 24% for the sialidase-treated RBCs, 
37 +lO% for the sialidase- plus endoglycosidase-, and 28 -t9% for the sialidase- 
plus P-D-galactosidase-treated RBCs, respectively. 
DISCUSSION 
The mechanism whereby RBCs are removed at the end of their life-span in 
circulation has been an intriguing question for many years. Briefly, the evidence 
favoring a role for the sialoglycoconjugates in RBC senescence and sequestration 
comes from the following six lines of investigation2i: (a) Analysis of the carbo- 
hydrate composition of young and old RBCs, (b) use of asialo-RBC as a model for 
RBC-senescence, (c) identification of the interaction of immunoglobulin with 
senescent RBCs and aRBCs, (d) studies on the inhibition of interaction of 
senescent RBCs with macrophages and immunoglobulins, (e) correlations derived 
from a study of the RBC sialoglycoconjugates in the anemias, and (f) isolation of a 
putative senescence factor glycopeptide. 
The circumstantial evidence thus collected implicates the involvement of a 
change in the chemical structure of the RBC membrane, as well as a change in its 
physical properties. A number of investigators have come to the same conclusion, 
but ascribe22 the nature of the chemical change either to the involvement of Band 
3, the exposure of a terminal a-o-galactosyl groupZ3. or to the PD-Galp-(1+3)-r>- 
GalpNAc group of a glycophorin-like molecule2’. Our evidence in support of a 
glycophorin-like molecule can be summarized as follows: (a) The presence of more 
galactose oxidase and sialyltransferase receptor sites in senescent as compared to 
young RBCs (ref. 3); (b) the ability to isolate6 from senescent, but not young. 
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RBCs a “senescence-factor glycopeptide” (SFG); (c) indications” from those 
properties of SFG utilized for its isolation as well as its reactivity with spleen mono- 
cytes. that SFG is biologically active; (d) the destruction of SFG’s interaction with 
spleen monocytes after its treatment with /3-n-galactosidase, attesting to the 
significant role of galactosyl residues in this biological activity6; (e) the ability of 
SFG to inhibit erythrophagocytosis at nanomoh concentrations, as compared to 
n-galactose at milkmolar and n-galactosyl groups bound to BSA at micromolur 
concentrations’; and (f) the ability of injected SFG from human senescent RBC to 
inhibit the uptake of mouse senescent RBC at the end of the RBC life-spanZ4. 
The aforementioned data are compatible with the hypothesis that a glyco- 
phorin-like molecule, devoid of sialic acid groups, could be the putative recognition 
factor on senescent RBCs. Since the homogeneity of SFG has not as yet been 
establishedh, it couId be argued that it is not necessarily a component of the glyco- 
phorin molecule that is involved, but another highly potent “senescence factor”, 
which would still contaminate the glycophorin glycopeptides that were isolated 
from the RBC-tryptic digest6 and used for the inhibition studies7. We have 
succeeded in showing, however, that the reduced survivability of aRBCs can be 
restored by removing the disaccharide groups. This “rejuvenation” of aRBCs by 
treatment with the endoglycosidase indicates that only the disaccharide groups 
exposed by the desialosylation of RBCs are detected by the reticula-endothelial 
system. 
Work in our laboratories and those of others has demonstrated significant 
differences in the behavior of asialo and senescent RBCs?‘. We attributed some of 
these differences primarily to the amount of sialic acid removed from the RBC. 
The observation that we can reverse the sequestration of aRBC by treatment with 
the endoglycosidase now provides us with a valuable tool to further explore this 
problem and eludicate the mechanism whereby senescent RBCs are recognized 
and sequestered. 
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